The FDA-Approved Oral Drug Nitazoxanide Amplifies Host Antiviral Responses and Inhibits Ebola Virus
- Luke D. Jasenosky
- , Cristhian Cadena
- , Chad E. Mire
- , Viktoriya Borisevich
- , Viraga Haridas
- , Shahin Ranjbar
- , Aya Nambu
- , Sina Bavari
- , Veronica Soloveva
- , Supriya Sadukhan
- , Gail H. Cassell
- , Thomas W. Geisbert
- , Sun Hur
- , Anne E. Goldfeld
Research output: Contribution to journal › Article › peer-review
116
Link opens in a new tab
Scopus
citations